enGene Holdings Inc. Announces Annual General Meeting on May 15, 2024

TL;DR

<b>enGene Holdings Inc. will hold its virtual Annual General Meeting on May 15, 2024, to vote on financial statements, director elections, and an equity plan amendment.</b>

AI Summary

enGene Holdings Inc. (ENGNW) filed a Proxy Statement (DEF 14A) with the SEC on April 18, 2024. The annual general meeting of enGene Holdings Inc. shareholders will be held virtually on May 15, 2024. Shareholders will vote on receiving the audited financial statements for the year ended October 31, 2023. Three director nominees will be elected to serve until the 2027 annual meeting. Shareholders will vote on an amendment to the 2023 Incentive Equity Plan to provide for annual increases in the Plan Share Reserve. The Plan Share Reserve increase will be 5% of outstanding Common Shares on the last day of the preceding calendar year.

Why It Matters

For investors and stakeholders tracking enGene Holdings Inc., this filing contains several important signals. This meeting is a key governance event where shareholders directly influence the company's leadership and equity incentive structure. The proposed amendment to the Incentive Equity Plan could impact future share dilution and employee compensation, requiring shareholder approval.

Risk Assessment

Risk Level: low — enGene Holdings Inc. shows low risk based on this filing. The filing is a routine proxy statement for an annual general meeting and does not contain new financial or operational information that would indicate significant risk.

Analyst Insight

Shareholders should review the proposed amendment to the Incentive Equity Plan and the director nominees before the May 15, 2024 meeting.

Key Numbers

• May 15, 2024 — Annual General Meeting Date (Date of the meeting)
• October 31, 2023 — Fiscal Year End (Period covered by audited financial statements)
• 3 — Directors to be Elected (Number of director nominees)
• 2027 — Director Term End (Year until which directors will serve)
• 5% — Annual Share Reserve Increase (Percentage of outstanding shares for annual increase)

Key Players & Entities

• enGene Holdings Inc. (company) — Registrant and company name
• May 15, 2024 (date) — Date of the annual general meeting
• October 31, 2023 (date) — End of fiscal year for financial statements
• 2027 (date) — Term for elected directors
• 2023 Incentive Equity Plan (plan) — Plan to be amended

FAQ

Risk Factors

• Compliance with SEC Regulations [low — regulatory]: The company must comply with all SEC rules and regulations regarding proxy solicitations and annual meetings.
• Virtual Meeting Format [low — operational]: Holding a virtual meeting may present challenges in shareholder engagement and accessibility compared to in-person meetings.
• Incentive Equity Plan Amendment [low — financial]: Approval of the amendment could lead to future share dilution, impacting existing shareholders' equity.

Key Dates

• 2024-05-15: Annual General Meeting — Shareholders will vote on key company matters.
• 2023-10-31: Fiscal Year End — Date for the audited financial statements.

Glossary

Incentive Equity Plan

A plan that provides employees with equity-based compensation. (Shareholders are voting on an amendment to this plan, which could affect future share dilution.)

Plan Share Reserve

The total number of shares available for issuance under an equity incentive plan. (The proposed amendment seeks to increase this reserve annually.)

Common Shares

The basic class of stock issued by a company. (These are the shares that will be used for the annual increase in the Plan Share Reserve.)

Filing Documents

• engene_2024_def14a.htm (DEF 14A) — 1138KB
• img18171159_0.jpg (GRAPHIC) — 8KB
• img18171159_1.jpg (GRAPHIC) — 617KB
• img18171159_2.jpg (GRAPHIC) — 308KB
• 0000950170-24-045297.txt (&nbsp;) — 2424KB

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 52 DIRECTOR COMPENSATION 63 EQUITY COMPENSATION PLAN INFORMATION 64 DIRECTORS&#x2019; APPROVAL 65 SCHEDULE A A- 1 SCHEDULE B B- 1 i QUESTIONS AND ANSWERS All amounts are in United States dollars (&#x201c; $&#x201d; or &#x201c; US$ &#x201d;), unless otherwise stated. Canadian dollars are presented as &#x201c; C$ &#x201d;, where indicated. Proxy Materials What is the format of the Meeting? The Meeting will be held in a virtual only format, which will be conducted via live audio webcast. Shareholders will not be able to attend the Meeting in person. We believe hosting a virtual annual meeting will enable shareholders to attend and participate fully and equally and improve our ability to effectively communicate and engage with our shareholders. A summary of the information shareholders will need to attend the Meeting online is provided below. Why am I receiving these materials? Our board of directors (the &#x201c; Board &#x201d;) is making these proxy materials available by mailing paper copies to you in connection with our Meeting to be held on May 15, 2024. You may also view the proxy materials online at https://materials.proxyvote.com/29286M. As a shareholder, you are invited to attend the virtual Meeting to be held via live webcast at www.virtualshareholdermeeting.com/ENGN2024 and are entitled and requested to vote on the business items described in this proxy statement. This proxy statement is furnished in connection with the solicitation of proxies by or on behalf of the Company's management. This proxy statement is designed to assist you in voting your shares and includes information that we are required to provide under the rules of the SEC and applicable Canadian securities laws. These proxy materials are being sent to both registered and non-registered shareholders. Please return your voting instructions as specified in the request for voting instructions. There are two kinds of non-registered, o

View Full Filing

View this DEF 14A filing on SEC EDGAR